Verve Therapeutics Inc (VERV) has gained Tuesday morning, with the stock adding 0.32% in pre-market trading to 9.32. VERV's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, the stock ranks higher than 0% of stocks. Verve Therapeutics Inc has fallen 20.60% over the past month, closing at $11.52 on October 17. During this period of time, the stock fell as low as $8.84 and as high as $20.12. VERV has an average analyst recommendation of Strong Buy. The company has an average price target of $43.67.
VERV has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on VERV!